Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volumes used. The aim of this project was to evaluate t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Format:	Artigo
Idioma:	Inglês
Publicat:	NIHR Journals Library 2024-10-01
Col·lecció:	Health Technology Assessment
Matèries:	ceftazidime-avibactam colistin drug resistance bacterial anti-bacterial agents cost-effectiveness analysis quality-adjusted life-years network meta-analysis oxacillinase expert testimony microbial sensitivity tests systematic review gram-negative bacterial infections
Accés en línia:	https://doi.org/10.3310/YAPL9347
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!